about
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?Stopping higher-risk myelodysplastic syndrome in its tracks.Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.The Wilms' tumor gene-1 is a prognostic factor in myelodysplastic syndrome: a meta analysis.Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Transplantation for myelodysplastic syndromes 2013.
@en
Transplantation for myelodysplastic syndromes 2013.
@nl
type
label
Transplantation for myelodysplastic syndromes 2013.
@en
Transplantation for myelodysplastic syndromes 2013.
@nl
prefLabel
Transplantation for myelodysplastic syndromes 2013.
@en
Transplantation for myelodysplastic syndromes 2013.
@nl
P2860
P1476
Transplantation for myelodysplastic syndromes 2013.
@en
P2093
Bart L Scott
Jennifer E Vaughn
P2860
P304
P356
10.1097/MOH.0B013E328364F547
P577
2013-11-01T00:00:00Z